-+ 0.00%
-+ 0.00%
-+ 0.00%
Pathos AI closed a $237 million Series E round to expand the smart AI drug development platform and advance the oncology pipeline.
Share
Listen to the news
Pathos AI closed a $237 million Series E round to expand the smart AI drug development platform and advance the oncology pipeline.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending